- Report
- May 2024
- 134 Pages
Global
From €6071EUR$6,499USD£5,136GBP
- Report
- June 2024
- 200 Pages
Global
From €7427EUR$7,950USD£6,283GBP
- Report
- February 2022
- 269 Pages
Global
From €8875EUR$9,500USD£7,508GBP
- Report
- October 2023
- 145 Pages
Global
From €2943EUR$3,150USD£2,490GBP
- Report
- January 2024
- 75 Pages
Global
From €3500EUR$4,013USD£3,065GBP
Clobetasol is a topical corticosteroid used to treat a variety of skin conditions, including eczema, psoriasis, and dermatitis. It is a potent drug, and is available in a variety of forms, including creams, ointments, gels, and solutions. Clobetasol is often used to treat severe cases of skin conditions, as it is more potent than other topical corticosteroids. It is also used to treat skin conditions that are resistant to other treatments.
Clobetasol is part of the larger dermatological drugs market, which includes a variety of treatments for skin conditions. These treatments range from topical creams and ointments to oral medications and injections. The dermatological drugs market is highly competitive, with a variety of companies offering products for a variety of skin conditions.
Some of the companies in the Clobetasol market include GlaxoSmithKline, Mylan, and Sun Pharmaceuticals. Other companies include Cipla, Dr. Reddy's Laboratories, and Lupin Pharmaceuticals. Show Less Read more